Efficient CD44-targeted magnetic resonance imaging (MRI) of breast cancer cells using hyaluronic acid (HA)-modified MnFe2O4 nanocrystals

Nanoscale Research Letters

Volumn 8, Issue 1, 2013, Pages 1-9

  Lee, Taeksu ^a   Lim, Eun Kyung ^b,c   Lee, Jaemin ^a   Kang, Byunghoon ^a   Choi, Jihye ^a   Park, Hyo Seon ^a   Suh, Jin Suck ^b,c   Huh, Yong Min ^b,c   Haam, Seungjoo ^a,c  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Colloidal nanoparticles; Hyaluronic acid; Magnetic resonance imaging; Nanobioimaging; Nanomedicine

Indexed keywords

BIOCOMPATIBILITY; DIAGNOSIS; DISEASES; IRON COMPOUNDS; MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; MEDICAL NANOTECHNOLOGY; MOLECULAR IMAGING; NANOCRYSTALS; NANOMAGNETICS; ORGANIC ACIDS; PHYSICOCHEMICAL PROPERTIES; RESONANCE; SYNTHESIS (CHEMICAL);

BREAST CANCER CELLS; COLLOIDAL NANOPARTICLES; CONTRAST AGENT; EFFICIENT DETECTION; HYDROXYL GROUPS; NANOBIOIMAGING; POLYSORBATE 80; TUMOR DIAGNOSIS;

HYALURONIC ACID;

EID: 84876889241     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-8-149     Document Type: Article

References (55)

1. Lee Y, Lee H, Kim YB, Kim J, Hyeon T, Park H, Messersmith PB, Park TG: Bioinspired surface immobilization of hyaluronic acid on monodisperse magnetite nanocrystals for targeted cancer imaging. Adv Mater 2008, 20:4154-4157.
2. Ponta H, Sherman L, Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003, 4:33-45.
3. Gotte M, Yip GW: Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006, 66:10233-10237.
4. Rochman M, Moll J, Herrlich P, Wallach SB, Nedvetzki S, Sionov RV, Golan I, Ish-Shalom D, Naor D: The CD44 receptor of lymphoma cells: structure-function relationships and mechanism of activation. Cell Adhes Commun 2000, 7:331-347.
5. Wallach-Dayan SB, Grabovsky V, Moll J, Sleeman J, Herrlich P, Alon R, Naor D: CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. J Cell Sci 2001, 114:3463-3477.
6. Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y: CD44 in cancer. Crit Rev Cl Lab Sci 2002, 39:527-579.
7. Bourguignon LYW, Peyrollier K, Gilad E, Brightman A: Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem 2007, 282:1265-1280.
8. Sugahara KN, Murai T, Nishinakamura H, Kawashima H, Saya H, Miyasaka M: Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 2003, 278:32259-32265.
9. Peck D, Isacke CM: Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325. J Cell Sci 1998, 111:1595-1601.
10. Peck D, Isacke CM: CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Curr Biol 1996, 6:884-890.
11. Chung HJ, Lee H, Bae KH, Lee Y, Park J, Cho SW, Hwang JY, Park H, Langer R, Anderson D, Park TG: Facile synthetic route for surface-functionalized magnetic nanoparticles: cell labeling and magnetic resonance imaging studies. ACS Nano 2011, 5:4329-4336.
12. Choi KY, Min KH, Na JH, Choi K, Kim K, Park JH, Kwon IC, Jeong SY: Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J Mater Chem 2009, 19:4102-4107.
13. Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Lee JH, Kim K, Kwon IC, Kim DD: Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic (R) for tumor-targeted delivery of docetaxel. Biomaterials 2011, 32:7181-7190.
14. Park W, Kim KS, Bae BC, Kim YH, Na K: Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur J Pharm Sci 2010, 40:367-375.
15. Kamat M, El-Boubbou K, Zhu DC, Lansdell T, Lu XW, Li W, Huang XF: Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages. Bioconjugate Chem 2010, 21:2128-2135.
16. Li F, Bae BC, Na K: Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells. Bioconjug Chem 2010, 21:1312-1320.
17. Lee DE, Kim AY, Yoon HY, Choi KY, Kwon IC, Jeong SY, Park JH, Kim K: Amphiphilic hyaluronic acid-based nanoparticles for tumor-specific optical/MR dual imaging. J Mater Chem 2012, 22:10444-10447.
18. Peng XH, Qian XM, Mao H, Wang AY, Chen Z, Nie SM, Shin DM: Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomed 2008, 3:311-321.
19. Debouttiere PJ, Roux S, Vocanson F, Billotey C, Beuf O, Favre-Reguillon A, Lin Y, Pellet-Rostaing S, Lamartine R, Perriat P, Tillement O: Design of gold nanoparticles for magnetic resonance imaging. Adv Funct Mater 2006, 16:2330-2339.
20. Chen BD, Zhang H, Du N, Zhang B, Wu YL, Shi DL, Yang DR: Magnetic-fluorescent nanohybrids of carbon nanotubes coated with Eu, Gd Co-doped LaF3 as a multimodal imaging probe. J Colloid Interf Sci 2012, 367:61-66.
21. Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li G: Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004, 126:273-279.
22. Lim EK, Kim HO, Jang E, Park J, Lee K, Suh JS, Huh YM, Haam S: Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging. Biomaterials 2011, 32:7941-7950.
23. Lim EK, Yang J, Suh JS, Huh YM, Haam S: Self-labeled magneto nanoprobes using tri-aminated polysorbate 80 for detection of human mesenchymal stem cells. J Mater Chem 2009, 19:8958-8963.
24. Park J, Yang J, Lim EK, Kim E, Choi J, Ryu JK, Kim NH, Suh JS, Yook JI, Huh YM, Haam S: Anchored proteinase-targetable optomagnetic nanoprobes for molecular imaging of invasive cancer cells. Angew Chem Int Edit 2012, 51:945-948.
25. Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF, Langer R, Farokhzad OC: Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. P Natl Acad Sci USA 2008, 105:2586-2591.
26. Bourguignon LYW, Singleton PA, Diedrich F, Stern R, Gilad E: CD44 interaction with Na + -H + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 2004, 279:26991-27007.
27. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJJ: CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004, 64:5702-5711.
28. Kim E, Yang J, Park J, Kim S, Kim NH, Yook JI, Suh JS, Haam S, Huh YM: Consecutive targetable smart nanoprobe for molecular recognition of cytoplasmic microRNA in metastatic breast cancer. ACS Nano 2012, 6:8525-8535.
29. Choi R, Yang J, Choi J, Lim EK, Kim E, Suh JS, Huh YM, Haam S: Thiolated dextran-coated gold nanorods for photothermal ablation of inflammatory macrophages. Langmuir 2010, 26:17520-17527.
30. Choi J, Yang J, Bang D, Park J, Suh JS, Huh YM, Haam S: Targetable gold nanorods for epithelial cancer therapy guided by near-IR absorption imaging. Small 2012, 8:746-753.
31. Choi J, Yang J, Park J, Kim E, Suh JS, Huh YM, Haam S: Specific near-IR absorption imaging of glioblastomas using integrin-targeting gold nanorods. Adv Funct Mater 2011, 21:1082-1088.
32. Lim EK, Yang J, Suh JS, Huh YM, Haam S: Synthesis of aminated polysorbate 80 for polyplex-mediated gene transfection. Biotechnol Progr 2010, 26:1528-1533.
33. Sashidhar RB, Capoor AK, Ramana D: Quantitation of epsilon-amino group using amino-acids as reference-standards by trinitrobenzene sulfonic-acid - a simple spectrophotometric method for the estimation of hapten to carrier protein ratio. J Immunol Methods 1994, 167:121-127.
34. Portney NG, Singh K, Chaudhary S, Destito G, Schneemann A, Manchester M, Ozkan M: Organic and inorganic nanoparticle hybrids. Langmuir 2005, 21:2098-2103.
35. Seo SB, Yang J, Lee ES, Jung Y, Kim K, Lee SY, Kim D, Suh JS, Huh YM, Haam S: Nanohybrids via a polycation-based nanoemulsion method for dual-mode detection of human mesenchymal stem cells. J Mater Chem 2008, 18:4402-4407.
36. Lee J, Yang J, Seo SB, Ko HJ, Suh JS, Huh YM, Haam S: Smart nanoprobes for ultrasensitive detection of breast cancer via magnetic resonance imaging. Nanotechnology 2008, 19.
37. Son KK, Tkach D, Hall KJ: Efficient in vivo gene delivery by the negatively charged complexes of cationic liposomes and plasmid DNA. Biochim Biophys Acta 2000, 1468:6-10.
38. Boron WF, Boulpaep EL: Medical Physiology: A Cellular and Molecular Approach. 1st edition. Philadelphia: W.B. Saunders; 2003.
39. Prough DS, Bidani A: Hyperchloremic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. Anesthesiology 1999, 90:1247-1249.
40. Song Q, Ding Y, Wang ZL, Zhang ZJ: Tuning the thermal stability of molecular precursors for the nonhydrolytic synthesis of magnetic MnFe2O4 spinel nanocrystals. Chem Mater 2007, 19:4633-4638.
41. Lim EK, Jang E, Kim B, Choi J, Lee K, Suh JS, Huh YM, Haam S: Dextran-coated magnetic nanoclusters as highly sensitive contrast agents for magnetic resonance imaging of inflammatory macrophages. J Mater Chem 2011, 21:12473-12478.
42. Yoo D, Lee JH, Shin TH, Cheon J: Theranostic magnetic nanoparticles. Accounts Chem Res 2011, 44:863-874.
43. Wang ZJ, Boddington S, Wendland M, Meier R, Corot C, Daldrup-Link H: MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatr Radiol 2008, 38:529-537.
44. Yang HM, Lee HJ, Park CW, Yoon SR, Lim S, Jung BH, Kim JD: Endosome-escapable magnetic poly(amino acid) nanoparticles for cancer diagnosis and therapy. Chem Commun 2011, 47:5322-5324.
45. Lee N, Hyeon T: Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev 2012, 41:2575-2589.
46. Kaufmann J, Mohle K, Hofmann HJ, Arnold K: Molecular dynamics study of hyaluronic acid in water. Theochem-J Mol Struc 1998, 422:109-121.
47. Gillis P, Moiny F, Brooks RA: On T-2-shortening by strongly magnetized spheres: a partial refocusing model. Magnet Reson Med 2002, 47:257-263.
48. LaConte LE, Nitin N, Zurkiya O, Caruntu D, O'Connor CJ, Hu X, Bao G: Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity. J Magn Reson Imaging 2007, 26:1634-1641.
49. Qin J, Laurent S, Jo YS, Roch A, Mikhaylova M, Bhujwalla ZM, Muller RN, Muhammed M: A high-performance magnetic resonance imaging T-2 contrast agent. Adv Mater 2007, 19:2411-2411.
50. Hardy PA, Henkelman RM: Transverse relaxation rate enhancement caused by magnetic particulates. Magn Reson Imaging 1989, 7:265-275.
51. Georgiadis JG, Ramaswamy M: Magnetic resonance imaging cooled of water freezing in packed beds from below. Int J Heat Mass Tran 2005, 48:1064-1075.
52. Kim E, Jung Y, Choi H, Yang J, Suh JS, Huh YM, Kim K, Haam S: Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. Biomaterials 2010, 31:4592-4599.
53. Ohya Y, Takeda S, Shibata Y, Ouchi T, Kano A, Iwata T, Mochizuki S, Taniwaki Y, Maruyama A: Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles. J Control Release 2011, 155:104-110.
54. Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C, Liu FF: Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 2006, 12:5726-5732.
55. Cui D, Han Y, Li Z, Song H, Wang K, He R, Liu B, Liu H, Bao C, Huang P, Ruan J, Gao F, Yang H, Cho HS, Ren Q, Shi D: Fluorescent magnetic nanoprobes for in vivo targeted imaging and hyperthermia therapy of prostate cancer. Nano Biomed Eng 2009, 1:61-74